From July 8 to 12, 2025, the 15th European Paediatric Neurology Society Congress (EPNS Congress 2025) took place in Munich, Germany. This event is one of the largest international platforms in the field of pediatric neurology, annually bringing together leading experts, scientists, and representatives of the pharmaceutical industry from around the world.

Pharm&Access LLP actively participated in the congress. Our representatives attended scientific sessions, symposia, workshops, and round tables dedicated to current issues in the diagnosis, treatment, and research of neurological disorders in children. The main theme of this year’s Congress focused on interdisciplinary collaboration for the benefit of children with neurological diseases, as well as the development of innovative approaches to the treatment of rare neurological conditions.
Participation in such international events enables Pharm&Access LLP to stay up to date with the latest scientific developments and to strengthen partnerships with leading European and global experts in the fields of medicine and pharmaceuticals.
We sincerely thank the organizers of EPNS Congress 2025 for the high level of the event and are confident that the knowledge and connections gained will contribute to the further development of our company in delivering quality medical and pharmaceutical services.

#EPNS2025 #PaediatricNeurology #ChildNeurology #PharmaIndustry #HealthcareInnovation #PharmAndAccess #MedicalScience #NeurologyConference #GlobalHealthcare #MedicalPartnerships #RareDiseases #ClinicalResearch #NeuroScience #Pharmaceuticals #MedicalCommunity